Publikation:
Developing human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020-2030

Kurzanzeige
dc.contributor.authorJeddi, Maryam Zare
dc.contributor.authorConrad, André
dc.contributor.authorHopf, Nancy B.
dc.contributor.authorLouro, Henriqueta
dc.contributor.authorKolossa-Gehring, Marike
dc.date.accessioned2024-06-16T13:10:34Z
dc.date.available2024-06-16T13:10:34Z
dc.date.issued2022
dc.description.abstractHuman biomonitoring (HBM) is a crucial approach for exposure assessment, as emphasised in the European Commissionâ€Ìs Chemicals Strategy for Sustainability (CSS). HBM can help to improve chemical policies in five major key areas: (1) assessing internal and aggregate exposure in different target populations; 2) assessing exposure to chemicals across life stages; (3) assessing combined exposure to multiple chemicals (mixtures); (4) bridging regulatory silos on aggregate exposure; and (5) enhancing the effectiveness of risk management measures. In this strategy paper we propose a vision and a strategy for the use of HBM in chemical regulations and public health policy in Europe and beyond. We outline six strategic objectives and a roadmap to further strengthen HBM approaches and increase their implementation in the regulatory risk assessment of chemicals to enhance our understanding of exposure and health impacts, enabling timely and targeted policy interventions and risk management. These strategic objectives are: 1) further development of sampling strategies and sample preparation; 2) further development of chemical-analytical HBM methods; 3) improving harmonisation throughout the HBM research life cycle; 4) further development of quality control / quality assurance throughout the HBM research life cycle; 5) obtain sustained funding and reinforcement by legislation; and 6) extend target-specific communication with scientists, policymakers, citizens and other stakeholders. HBM approaches are essential in risk assessment to address scientific, regulatory and societal challenges. HBM requires full and strong support from the scientific and regulatory domain to reach its full potential in public and occupational health assessment and in regulatory decision-making. © 2022 The Authorsen
dc.format.extent1 Onlineressource (21 pages)
dc.format.mediumonline resource
dc.identifier.doihttps://doi.org/10.60810/openumwelt-718
dc.identifier.urihttps://openumwelt.de/handle/123456789/2601
dc.language.isoeng
dc.rights.urihttp://rightsstatements.org/vocab/InC/1.0/
dc.subjectHuman-Biomonitoring
dc.subjectKreislaufwirtschaft
dc.titleDeveloping human biomonitoring as a 21st century toolbox within the European exposure science strategy 2020-2030
dc.typeWissenschaftlicher Artikel
dc.type.dcmitext
dc.type.mediumcomputer
dspace.entity.typePublication
local.bibliographicCitation.journalTitleEnvironment International
local.bibliographicCitation.originalDOI10.1016/j.envint.2022.107476
local.bibliographicCitation.volume168 (2022)
local.collectionAufsätze
local.contributor.authorId02188511
local.contributor.authorId02161549
local.contributor.authorId02182514
local.identifier.catalogId02492968
local.ingest.leader06268naa a2200000uu 4500
local.jointTitleDEVELOPING HUMAN BIOMONITORING AS A 21ST CENTURY TOOLBOX WITHIN THE EUROPEAN EXPOSURE SCIENCE STRATEGY 20202030
local.reviewtrue
local.sourcecatalog
local.source.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.de
local.staffPublicationtrue
relation.isAuthorOfPublicationbb0eb320-1a69-4eb7-8a9a-2be778f049d7
relation.isAuthorOfPublication0c3b6c3e-eff4-42d8-94e9-07a4fee4049c
relation.isAuthorOfPublication.latestForDiscoverybb0eb320-1a69-4eb7-8a9a-2be778f049d7
Dateien
Sammlungen
Aufsätze